Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

In recent trading, Tevogen Bio Holdings Inc (TVGN) stock price has shown some volatility, fluctuating -32.55% over the last five trades and 438.34% over the past 30 trades. This represents a notable ...

CD8 Technology Services, LLC (“CD8 Technology”) to provide turn-key facility for Tevogen BioReinforces Tevogen Bio’s ...

By leveraging Microsoft's advanced tool collection, Tevogen Bio aims to establish an oncology product portfolio.

WARREN, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty ...

Tevogen Bio Inc. has begun preclinical efforts for TVGN-920, its first oncology product. The company is leveraging ...

WARREN, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty ...

Tevogen AI, Tevogen Bio's artificial intelligence effort, has joined Microsoft for Startups. Microsoft for Startups grants Tevogen AI access to Microsoft's ecosystem, speeding up the development ...

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 ...

WARREN, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, ...